Want to see JP:7061 full AI Analyst Report?

Japan Hospice Holdings Inc. (7061) Price & Analysis

0 Followers

7061 Stock Chart & Stats

¥1120.00

¥7.00(0.51%)

At close: Jan 08 4:00 PM EST

¥1120.00

¥7.00(0.51%)

Day’s Range― - ―

52-Week Range¥509.00 - ¥1,578.00

Previous CloseN/A

Volume53.20K

Average Volume (3M)47.89K

Market Cap

¥4.74B

Enterprise Value¥17.36K

Total Cash (Recent Filing)¥1.78B

Total Debt (Recent Filing)¥13.06B

Price to Earnings (P/E)15.9

Beta1.10

Next Earnings

Aug 14, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.47%

Share Statistics

EPS (TTM)35.87

Shares Outstanding8,484,100

10 Day Avg. Volume91,680

30 Day Avg. Volume47,890

Financial Highlights & Ratios

PEG Ratio-0.59

Price to Book (P/B)2.56

Price to Sales (P/S)0.66

P/FCF Ratio-7.11

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)199.5

Revenue Forecast (FY)¥20.00B

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthSteady top-line growth across 2020–2025 demonstrates sustained demand for hospice and palliative services and successful facility utilization. Persistent revenue growth supports scale benefits, long-term service adoption, and predictable operating cash inflows over the next 2–6 months and beyond.

Positive Operating Cash FlowPositive and improving operating cash flow indicates core operations generate cash, supporting working capital and interest payments. While conversion is weak, sustained positive OCF reduces short-term liquidity stress and provides a foundation for funding operations and incremental investments over coming quarters.

Asset And Capacity ExpansionNet asset growth suggests the company is expanding facility footprint and capacity, which can deepen market presence in hospice care. Enlarged asset base supports revenue generation potential and long-term network effects, improving competitive position if utilization keeps pace with investment.

Bears Say

High LeverageA debt-to-equity ratio near 3.6x materially constrains financial flexibility, raising refinancing and interest-rate exposure. High leverage magnifies earnings volatility, reduces room for strategic investments, and increases default risk if operating performance or cash flows worsen over the medium term.

Margin CompressionSignificant gross and net margin deterioration points to rising operating costs or pricing pressure that erodes profitability. Lower margins weaken internal cash generation and returns on invested capital, making it harder to cover debt service and fund growth without external financing over the next several quarters.

Consistently Negative Free Cash FlowRepeated negative FCF indicates the business is not funding investments from operations, forcing reliance on debt or equity. Persistent FCF deficits limit ability to de-lever, pay dividends sustainably, or absorb shocks, heightening execution and financing risk over the medium term.

7061 FAQ

What was Japan Hospice Holdings Inc.’s price range in the past 12 months?

Japan Hospice Holdings Inc. lowest stock price was ¥509.00 and its highest was ¥1578.00 in the past 12 months.

What is Japan Hospice Holdings Inc.’s market cap?

Japan Hospice Holdings Inc.’s market cap is ¥4.74B.

When is Japan Hospice Holdings Inc.’s upcoming earnings report date?

Japan Hospice Holdings Inc.’s upcoming earnings report date is Aug 14, 2026 which is in 24 days.

How were Japan Hospice Holdings Inc.’s earnings last quarter?

Japan Hospice Holdings Inc. released its earnings results on May 15, 2026. The company reported ¥9.43 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Japan Hospice Holdings Inc. overvalued?

According to Wall Street analysts Japan Hospice Holdings Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Japan Hospice Holdings Inc. pay dividends?

Japan Hospice Holdings Inc. pays a Annually dividend of ¥25 which represents an annual dividend yield of 4.47%. See more information on Japan Hospice Holdings Inc. dividends here

What is Japan Hospice Holdings Inc.’s EPS estimate?

Japan Hospice Holdings Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Japan Hospice Holdings Inc. have?

Japan Hospice Holdings Inc. has 8,484,100 shares outstanding.

What happened to Japan Hospice Holdings Inc.’s price movement after its last earnings report?

Japan Hospice Holdings Inc. reported an EPS of ¥9.43 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.834%.

Which hedge fund is a major shareholder of Japan Hospice Holdings Inc.?

Currently, no hedge funds are holding shares in JP:7061

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Japan Hospice Holdings Inc.

Japan Hospice Holdings Inc. operates in Japan, focusing on two primary areas: hospice residential care and a range of home-based support services. Its hospice facilities offer specialized care for patients facing terminal cancer and intractable diseases. Beyond residential care, the company provides home-visit nursing and broader home care services. These home care offerings include medical assistance, physical care, and support for daily living, alongside multi-functional day and nursing care programs. The company was founded in 2017 and is headquartered in Tokyo, Japan.